Reportlinker Adds Global Blood Banking and Blood Products Industry

Oct 18, 2010, 12:26 ET from Reportlinker

NEW YORK, Oct. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Blood Banking and Blood Products Industry

http://www.reportlinker.com/p020749/Global-Blood-Banking-and-Blood-Products-Industry.html

This report analyzes the worldwide markets for Blood Banking & Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 205 companies, including leading blood banks such as AABB, America's Blood Centers, American Red Cross, Canadian Blood Services, CorCell Companies, Inc., Cord Blood Registry, Japan Red Cross, Lifebank Corp, National Blood Foundation, New England Cord Blood Bank, Inc., New York Blood Center, and VITA 34 AG. Some of the leading players in Blood Bank Technology & Supplies also discussed in this report include Beckman Coulter Inc., Becton Dickinson and Company, BioMerieux SA, Caridian BCT, Inc., Chiron, CSL Behring LLC, Daxor Corporation, Fenwal Inc., Fresenius SE, Gambro AB, Gen-Probe Incorporated, Haemonetics Corp, Hemagen Diagnostics Inc., Immucor Inc., Kawasumi Laboratories, Inc., Olympus America, Inc., PharmaStem Therapeutics, Inc., Terumo Corporation, ThermoGenesis Corp., and Velico Medical, Inc. Leading Players discussed under the Plasma Fractionation segment include Baxter International Inc., Bio Products Laboratory, CSL Limited, CSL Bioplasma, Grifols, Kedrion, Laboratorie Francais du Fractionnement et des Biotechnologies, Octapharma, Sanquin, and Talecris Biotherapeutics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

BLOOD BANKING & BLOOD PRODUCTS MCP-1028

A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 2

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

Blood Components and Plasma Products 3

Whole Blood & Cellular Components 4

WBCs 4

RBCs 4

Platelets 4

Plasma Fractions 4

Fresh Frozen Plasma 4

Albumin Fractions 5

Factor VIII 5

Factor IX and Factor IX Complex 5

Fibrin/Thrombin 5

Equipment, Blood Tests and Consumables 5

Automated Analyzers for Blood Analysis 5

Blood Tests 6

Consumables 6

2. MARKET OVERVIEW 7

Healthcare Scares Propel the Market 7

Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts 7

Worldwide Blood Banking and Blood Products Market at a

Glance (All figures are 2010 estimates & CAGR is for the

period 2007-2015) 8

Current & Future Analysis 8

Analysis by Geographic Region 8

Analysis by Product Segment 9

World Blood Components and Plasma Market Analysis in Units 9

Table 1: World Recent Past, Current & Future Analysis for

Blood Components and Plasma by Region/Country - USA, Europe,

Japan, and Rest of World Markets Independently Analyzed with

Annual Consumption in Million Units for Years 2007 through

2015 (includes corresponding Graph/Chart) 10

Table 2: World 9-Year Perspective for Blood Components and

Plasma by Region/Country - Percentage Breakdown of Volume

Consumption for USA, Europe, Japan, and Rest of World Markets

for Years 2007, 2010 & 2015 (includes corresponding

Graph/Chart) 11

Red Blood Cells - A Key Blood Component and a Major Contributor 12

Table 3: World Recent Past, Current & Future Analysis for

Red Blood Cells by Region/Country - USA, Europe, Japan, and

Rest of World Markets Independently Analyzed with Annual

Consumption in Million Units for Years 2007 through 2015

(includes corresponding Graph/Chart) 12

Table 4: World 9-Year Perspective for Red Blood Cells by

Region/Country - Percentage Breakdown of Volume Consumption

for USA, Europe, Japan, and Rest of World Markets for Years

2007, 2010 & 2015 (includes corresponding Graph/Chart) 13

3. MARKET TRENDS & ISSUES 14

New Infections - A Continuous Threat 14

Safety and Availability: The Core Issues 14

Decontamination: A Viable Process 15

New Processes for Safer Blood Supply 15

Innovative Procedures Help Blood Conservation 15

Autologous Transfusion Strapping up for High Growth 15

Enzyme Converted Cells Set to Rule the Industry 16

Blood Unavailability: Substitutes to the Rescue 16

Transfusions: Hospitals Making Way for Others 16

Computer Identification Helps Patients 17

SARS: A Case of Mistaken Identity? 17

Pooling: Economical HIV Testing 17

Private Cord Blood Banking: Flying High Despite Opposition 17

Consolidation Whittles Down Number of Market Players 17

Table 5: Leading Players in the Global Blood Screening Market

(2008) (includes corresponding Graph/Chart) 18

Table 6: Leading Players in the Global Plasma Derived

Products Market (2008): Market Share in terms of Revenues for

Baxter, CSL, Octapharma, Talecris and Grifols (includes

corresponding Graph/Chart) 18

Table 7: Market Shares of CSL Behring and Talecris in Select

Plasma Product Markets in terms of Revenues (2008) (includes

corresponding Graph/Chart) 19

Automation of Blood Banking - Nearing the Efficiency Frontier? 19

Automated Instrumentation Taking the Front Seat 19

Table 8: World Market for Blood Bank Technology (2007):

Percentage Breakdown of Revenues by Segment - Manual Blood

Bag Systems, Automated Systems, Component Lab, Commercial

Plasma, Blood Salvage, and Pathogen Inactivation (includes

corresponding Graph/Chart) 20

Table 9: Leading Players in the World Market for Automated

Collection of Blood Components using Apheresis Technology

(2005 - A Historic Review): Percentage Breakdown of Revenues

for Gambro, Baxter, Haemonetics, Fresenius, and Others

(includes corresponding Graph/Chart) 20

Plasma Market: Automation Making Inroads 20

The RBC Market - Slow to Catch Up 20

Automation of Testing - Yet to Mature 21

Automation to Suffice Shortage Problems 21

How Near to the Efficiency Frontier? 21

4. PRODUCT OVERVIEW 22

Blood Banking and Blood Products Industry 22

Blood Components and Plasma Products 22

Equipment, Blood Tests and Consumables 22

Automated Analyzers for Blood Analysis 22

Blood Tests 22

Consumables 23

Blood Collection Equipment 23

Blood Collection Monitors 23

Blood Donor Couches 23

Blood Processing Equipment 23

Blood Bank Centrifuges 23

Plasma Thawing 23

Blood Cell Separators 24

Blood Storage Equipment 24

Blood Bags 24

Platelet Agitators 24

Blood Bank Refrigerators 24

Blood - A Primer 24

Ionic Structure 24

Blood Components and their Applications 25

Blood Constituents 26

Plasma 26

Red Blood Cells (RBC) 26

Blood Count 27

Platelets 27

Table 10: Platelets (Leucodepleted) Issued by Select Region/

Agency (2005) (includes corresponding Graph/Chart) 28

White Blood Cells (WBC) 28

Derivative Products of Blood or Plasma Fractions 29

Plasma Protein and Fractionation 29

The Need 29

Fresh Frozen Plasma 29

Other Plasma Fractions 30

Albumin Fractions 30

Albumin Usage Rising in Profile, Wastage Worries Run Deep 30

Immunoglobulins 30

Table 11: Leading Countries in IVIg Usage Rates in Grams per

1000 Population (includes corresponding Graph/Chart) 30

Hyper-Immune Immunoglobulin 31

Factor VIII 31

Table 12: Leading Players in World Market for Factor VIII

(2006): Percentage Breakdown of Revenues for Baxter, Bayer

(Kogenate), CSL Behring (Helixate) and Wyeth (includes

corresponding Graph/Chart) 31

Factor IX and Factor IX Complex 31

Fibrin/Thrombin 31

Consumption of Blood Based on Type of Surgery/ Accident (In

Units) 32

Table 13: World Market for Plasma Derivatives (2009):

Percentage Breakdown of Revenues by Region/Country - USA,

Europe, Asia-Pacific, Latin America, and Rest of World

(includes corresponding Graph/Chart) 32

Table 14: World Market for Plasma Derivatives (2006):

Percentage Breakdown of Revenues by Product Type - IVIg,

Factor VIII, Albumin, Hyperimmunes, Factor IX and Others

(includes corresponding Graph/Chart) 32

Table 15: Plasma Collection in Select Countries in Thousand

Liters (includes corresponding Graph/Chart) 33

Recombinant Products 33

Therapeutic Uses of Plasma Products 33

Albumin Products 34

Immunoglobulins 34

Intravenous Immunoglobulin (IVIg) 34

Normal Immunoglobulin (IMIg) 34

CMV Immunoglobulin 34

Hepatitis B Immunoglobulin 35

Rh (D) Immunoglobulin 35

Tetanus Immunoglobulin IM 35

Zoster Immunoglobulin 35

Plasma Derived Coagulant Products 35

Biostate® 35

Ceprotin® 35

Factor VII Concentrate 36

Factor XI Concentrates 36

Feiba VH® Inhibitor Treatment 36

Fibrogammin P® 36

Monofix®-VF 36

ProthrombinexTM-HT 36

Thrombotrol®-VF 36

5. BLOOD COLLECTION METHODS 37

Banking the Natural Blood Resources 37

Blood Banks 37

Blood Banking 37

Blood Transfusion 37

Role of Blood Banks 37

Blood Donor: The Epicenter of the Process 37

Eligibility Criteria for the Donor 38

The Basics of Blood Donation - Myths Exploded & Other Facts 38

Table 16: Active Donors of Whole Blood and Apheresis per

1,000 of Population by Country/Agency (includes

corresponding Graph/Chart) 39

Table 17: Percentage Breakdown of Apheresis and Whole Blood

Donations by Country (2005) (includes corresponding

Graph/Chart) 40

Collection Methods 40

Blood Donation: The Process 40

Types of Blood Donation 40

Directed Blood Donations 40

Autologous Blood Donation 41

Alternative Usage of Patient's Own Blood 41

General Blood Donation 41

Hemodilution 41

Wound Drainage 41

Cell Saver 41

The Method 42

Blood Salvaging 42

Blood Collection Centers 42

Blood Collection Management System 42

A Historical Retrospective 42

Blood Collection Centers 43

Types of Blood Collection Centers 43

Cord Blood Banks 43

Profit Collection Centers 43

Military Blood Banks 43

Hospital Blood Banks 43

Community Blood Banks 44

Non-Profit Collection Centers 44

Blood Processing 44

Blood Typing 45

Rh Blood Group System 45

ABO Blood Group System 45

Blood Types and their Compatibility 46

Table 18: Occurrence of Blood Groups Worldwide (In %)

(includes corresponding Graph/Chart) 46

Blood Test 46

Blood Culture 47

The Costs 47

History of Blood Banking 47

6. THE CHANGING LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS 50

Blood Transfusion: A Backdrop 50

Massive Transfusion 50

Complications and Risks Due to Transfusion 50

Circulatory Overload 51

Graft Versus Host Disease (GVHD) 51

Haemolytic Transfusion Reactions 51

Iron Overload 51

Bacterial Contamination 51

Thrombophlebitis 51

Allergic Reactions 52

Air Embolism 52

Hyperkalaemia 52

Changing Role of Blood Banking Technology 52

7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES 53

Cross Matching 53

Blood Donor/Recipient Screening 53

Blood Typing 53

Leukoreduction 53

Leukocyte Reduction Specification Standards/Filters 54

Coombs Test 54

8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY 55

Bloodless Surgery 55

Therapeutic Apheresis 55

Plasmapheresis 55

Plateletpheresis 56

Leukapheresis 56

Volume Expanders 56

Colloids 56

Albumin 56

Dextrans 56

Hydroxyethyl Starch 57

Crystalloids 57

Blood Growth Factor Therapies - Newer Alternatives to Transfusion 57

9. BLOOD SUBSTITUTES 58

Blood Substitutes Under Development by Manufacturers 58

Synthetic Blood Manufacturers/Developers 59

Alliance Pharmaceuticals Corp. (USA) 59

Biopure Corporation (USA) 59

Enzon Pharmaceuticals (USA) 60

Hemosol Inc. (Canada) 60

Northfield Laboratories Inc. (USA) 60

Synthetic Blood International, Inc. (USA) 60

10. PRODUCT INTRODUCTIONS/INNOVATIONS 61

Fenwal Receives US FDA Clearance for Fenwal Amicus® Separator

System 61

FamilyCord Introduces New More Efficient and Safe Cord Blood

Collection Kit 61

BD Unveils BD Microtainer® MAP Microtube 61

Pall Releases Advanced Blood Filter 62

Fenwal Responds to Haemonetics' New Lawsuit Against Alyx® System 63

CaridianBCT Rolls Out RBCX Protocol 63

ITL Launches TEGO™ Animal Blood Collection Kit 64

Fenwal to Launch Modified ALYX Kit 64

QIAGEN Launches New QIAsafe DNA Blood Products 64

Gambro Introduces New Prismaflex eXeed™ System 65

AnaSpec Unveils 'SensoLyte® Rh110 Plasmin Activity Assay Kit 65

Typenex® Medical Rolls Out New Barcode Blood Band 66

Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry

Analyzer System 66

BD Diagnostics Launches BD BACTEC™ FX Blood Culture System 66

Beckman Coulter Launches UniCel DxH 800 Coulter® Cellular

Analysis System 67

Diazyme Secures FDA Clearance for Marketing Liquid Stable

Enzymatic Lithium Test 68

ThermoGenesis Launches New Range of Veterinary POC Products 68

Prometheus Develops First Blood Test for IBS Diagnosis 69

CaridianBCT Introduces 'Atreus® 3C Whole Blood Processing

System' 69

GeneNews Unveils ColonSentry™ for Diagnosing Colorectal Cancer 69

Haemonetics Upgrades PCS®2 System with Quicker Plasma

Collection Software 70

11. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST - A PERSPECTIVE

BUILDER 71

Olympus Launches AU680® Chemistry Analyzer 71

Haemonetics Software Expands Symphony 2.0 Software with New

Module71Gen-Probe Introduces APTIMA® HPV Assay 71

Olympus Life Science Europa Introduces Automated HbA1c Assay 72

Haemonetics Unveils New Plasma Collection Software 72

Pall Unveils Acrodose™ PLus System 72

Z-Medica Rolls Out Rapid Blood Clotting Products in the

Consumer Market 72

Dade Behring Launches the Quadriga BeFree System 73

Swedish Inventors Develop New Processing System 73

Canada Invents New Method for Monitoring Blood and Blood Products 73

Terumo Launches Improvised Bags For Safe Blood Collection 73

Haemonetics Launches Cymbal Automated Blood Collection System 74

12. PRODUCT APPROVALS IN THE RECENT PAST 75

Cerus Receives CE Mark Approval for the Intercept Blood System

for Platelets 75

Haemonetics Wins FDA Approval for the ACP 215 System 75

Biomerieux' Polycarbonate BacT/ALERT Receives US FDA Clearance 75

Pall's eBDS Receives Green Signal from FDA 76

CardioPAT™ Surgical Blood Salvage System 76

PCS® 2 - Set to Enhance Plasma Quality 76

Dade Behring's D-Dimer Assay Strapping up for Roll Out 76

13. RECENT INDUSTRY ACTIVITY 77

HemaCare Signs Two New Blood Service Contracts 77

Cord Blood Acquires Majority Stake in Stellacure 77

Haemonetics Gains Rights to Alba's Full Line of Blood Typing

Reagents 78

ThermoGenesis Inks Deal with Fenwal and Enters Asian Markets 78

CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel®

Automated Blood Collection System 79

American Red Cross Inks 3-Year Deal with ITL 79

FDA Grants 510(K) Clearance for Expanded Use of Haemonetics 80

ThermoGenesis and GE Healthcare Enter into Distribution Deal 80

Daxor's Idant Labs Bags Blood Banking Contract from RMSB&G 81

Beckman Coulter Agrees to Distribute CellaVision Digital

Morphology Products 81

Haemonetics to Acquire Global Med 82

Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments 82

PathCare Establishes New Cord Blood Stem Cell Banking Facility 83

MRHC Obtains License for SafeTrace Tx Solution of Global Med 83

Life Technologies to Acquire AcroMetrix 83

Fenwal Secures FDA Approval for New Platelet Additive Solution 84

Daxor Sells Blood Volume Analyzer to MUSC 84

Heska Enters into a Supply Agreement with Roche Diagnostics 85

BLOOD Bank of Alaska Obtains License for Mediware's LifeTrak

Technology 85

Europe and the US Expand Blood Banking Agreement 86

Daxor to Provide BVA-100 Blood Volume Analyzer to Durham VA

Medical Center 86

Pfizer Acquires Wyeth 86

Baxter Inaugurates New BLOOD Plasma Fractionation Facility in

Vienna 87

ProMetic Acquires Majority Shareholding in PRDT 87

BD Diagnostics Bags FDA Approval for BD Vacutainer® Rapid

Serum Tube 87

Cadila to Establish Biosimilars Manufacturing Plant 88

China Biologic to Collaborate with IBT on Research & Development 88

Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test 88

Gen-Probe to Establish Independent New Firm for Industrial

Testing 89

Haemonetics Acquires SEBRA Blood Collection & Processing Unit 90

Beckman Coulter Acquires Lab-Based Diagnostics Business of

Olympus 91

Daxor to Provide BVA-100 Blood Volume Analyzer to Pacific

Cardiology 91

Golden Meditech and Fenwal to Establish a Blood Collection

Joint Venture in China 91

PRCS Inaugurates State-of-the-Art Blood Bank 92

CSL and Talecris Terminate Merger Agreement 92

Immucor Inks 5-Year Deal with Alverno 92

Gen-Probe Acquires Tepnel and Renews Partnership with Novartis 93

Haemonetics Takes Over Neoteric Technology 93

Haemonetics Acquires Altivation Software 94

PacifiCord Sets Up Cord Blood Banking Facility in Irvine 95

China Biologic Acquires 35% Stake in Xi'an Huitian Blood

Products 95

Biocell and Cellsense Merge 95

Octapharma Plans to Set Up Fractionation Facility 95

Therapure BioPharma Inks Development Services Deal with LFB

Biotechnologies 96

Strassenburg and CordLife to Establish Blood Banking Facility

in Kolkata, India 96

Biotest Acquires Blood Plasma Collection Center from Talecris 96

NCRM and Jeevan Stem Cell Bank Signs MoU for Cord Blood Stem

Cells Research 96

TCH of Tahlequah Acquires Daxor's BVA-100 Blood Volume Analyzer 97

Gen-Probe Expands and Extends Blood Screening Alliance with

Novartis 97

Celestial Biologicals Collaborates With GE Healthcare for

Indian Market 98

China Biologic to Purchase Stake in Dalin 98

Cerus Enters Into Deal with Fenwal 98

Bennnett, Coleman Picks Up Minority Stake in Stem One

Biologicals 99

Cryo-Cell Renews Exclusive Retailer Agreement with Upromise® 99

Pantheon China to Take Over China Cord Blood Services 99

United Blood Services to Divest Jackson Operations to

Mississippi Blood Services 100

ITL Signs Agreement with Blood Centers of America 100

CaridianBCT Mirasol PRT System Receives CE Mark Approval 100

CaridianBCT Signs Deal with American Red Cross for Automated

Blood Collection Technology 100

Genzyme Japan to Acquire Lymphoglobuline Marketing from CSL

Behring 101

Biotest Diagnostics and GSABC Ink a Deal 101

Blood Cell Storage Inks Option Agreement With CaridianBCT 102

CBB Inaugurates Donor Facility In Indio 102

CSL to Acquire Talecris 102

Novartis Diagnostics Gains FDA Clearance for PROCLEIX®

ULTRIO® Assay 103

ViaCord to Collaborate with Mia Hamm Foundation 103

Octapharma to Take Over Plasma Centers from International

BioResources 104

America's Blood Centers and MDA Ink a Contingency Deal 104

Piramal Healthcare Enters into an Agreement with PlasmaSelect 104

Grifols Secures Commercial Loan for Purchasing Plasma Centres 105

Cytori Inks Supplying Agreement with Biohellenika 105

Animal Blood Bank and Midwest Animal Blood Services Merge to

Form Animal Blood Resources 105

Gambro Gains FDA Approval for Sale of Atreus® 105

Cerus Signs Agreement for INTERCEPT Platelet System Supply 106

Haemonetics Teams Up with Octapharma for Plasma Collection

Technology 106

Gambro Inks Deal with S.C.M to Divest Its Bloodline

manufacturing Unit 106

Octapharma Acquires PVG 107

14. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 108

15. FOCUS ON SELECT GLOBAL PLAYERS 139

Leading Blood Banks 139

AABB (USA) 139

America's Blood Centers (USA) 139

American Red Cross (USA) 139

Canadian Blood Services (Canada) 140

CorCell Companies Inc. (USA) 140

Cord Blood Registry (USA) 141

Japan Red Cross Society (Japan) 141

Lifebank Corp. (Canada) 141

National Blood Foundation (USA) 142

New England Cord Blood Bank, Inc. (USA) 142

New York Blood Center (USA) 142

VITA 34 AG (Germany) 143

Leading Players in Blood Bank Technology and Supplies 143

Beckman Coulter, Inc. (USA) 143

Becton, Dickinson and Company (USA) 143

BioMerieux SA (France) 143

Caridian BCT, Inc (USA) 144

Chiron (USA) 144

CSL Behring LLC (USA) 145

Daxor Corporation (USA) 145

Fenwal Inc., (USA) 145

Fresenius SE (Germany) 146

Gen-Probe, Inc. (USA) 146

Haemonetics Corp. (USA) 147

Hemagen Diagnostics Inc. (USA) 147

Immucor Inc. (USA) 147

Kawasumi Laboratories, Inc. (Japan) 148

PharmaStem Therapeutics, Inc. (USA) 148

Terumo Corp. (Japan) 149

ThermoGenesis Corp. (USA) 149

Velico Medical, Inc. (USA) 149

Leading Players in Plasma Fractionation 150

Baxter International Inc. (USA) 150

Bio Products Laboratory (UK) 150

CSL Limited (Australia) 150

CSL Bioplasma (Australia) 150

Grifols (Spain) 151

Kedrion (Italy) 151

Laboratoire Francais du Fractionnement et des Biotechnologies

(France) 151

Octapharma (Switzerland) 152

Sanquin (The Netherlands) 152

Talecris Biotherapeutics (USA) 152

16. GLOBAL MARKET PERSPECTIVE 153

Table 19: World Recent Past, Current & Future Analysis for

Blood Banking and Blood Products by Geographic Region - USA,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 153

Table 20: World Historic Review for Blood Banking and Blood

Products by Geographic Region - USA, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 154

Table 21: World 10-Year Perspective for Blood Banking and

Blood Products by Geographic Region - Percentage Breakdown of

Value Sales for USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 155

Table 22: World Recent Past, Current & Future Analysis for

Blood Components and Plasma Products by Geographic Region -

USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 156

Table 23: World Historic Review for Blood Components and

Plasma Products by Geographic Region - USA, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 157

Table 24: World Recent Past, Current & Future Analysis for

Blood Components and Plasma Products by Product Group - Whole

Blood & Cellular Components, and Plasma Fractions Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 158

Table 25: World Historic Review for Blood Components and

Plasma Products by Product Group - Whole Blood & Cellular

Components, and Plasma Fractions Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2001 through 2006 (includes corresponding Graph/Chart) 159

Table 26: World 10-Year Perspective for Blood Components and

Plasma Products by Geographic Region - Percentage Breakdown of

Value Sales for USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 160

Table 27: World 10-Year Perspective for Blood Components and

Plasma Products by Product Segment - Percentage Breakdown of

Value Sales for Whole Blood & Cellular Components, and Plasma

Fractions Markets for Years 2005, 2010 & 2015 161

Table 28: World Recent Past, Current & Future Analysis for

Whole Blood & Cellular Components by Geographic Region - USA,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2007 through

2015 (includes corresponding Graph/Chart) 162

Table 29: World Historic Review for Whole Blood & Cellular

Components by Geographic Region - USA, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Sales in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 163

Table 30: World 10-Year Perspective for Whole Blood & Cellular

Components by Geographic Region - Percentage Breakdown of

Value Sales for USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 164

Table 31: World Recent Past, Current & Future Analysis for

Plasma Fractions by Geographic Region - USA, Canada, Japan,

Europe, Asia-Pacific (excluding Japan), Latin America and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 165

Table 32: World Historic Review for Plasma Fractions by

Geographic Region - USA, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 166

Table 33: World 10-Year Perspective for Plasma Fractions by

Geographic Region - Percentage Breakdown of Value Sales for

USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan),

Latin America and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 167

Table 34: World Recent Past, Current & Future Analysis for

Equipment, Blood Tests and Other Consumables by Geographic

Region - USA, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) 168

Table 35: World Historic Review for Equipment, Blood Tests

and Other Consumables by Geographic Region - USA, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) 169

Table 36: World 10-Year Perspective for Equipment, Blood

Tests and Other Consumables by Geographic Region - Percentage

Breakdown of Value Sales for USA, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 170

17. THE UNITED STATES 171

A.Market Analysis 171

Current and Future Analysis 171

Market Trends 171

Recession Impacts Blood Bank Reserves 171

US Blood Collection & Supply Profile 171

Blood Group Distribution 172

Table 37: US Market for Blood Banking and Blood Products:

Percentage Break up of Blood Group by Rh Factor (includes

corresponding Graph/Chart) 172

Table 38: Percentage Break up of Rh Blood Types in the US

by Racial Group 173

Blood Donated and Transfused Every Year 173

Males Form the Major Chunk of Donors 173

Cost of Blood 173

SARS Scares: Blood Banks Feel the Heat 173

Blood and Blood Preparations: A Recent Past Review of Trade

Statistics 174

Table 39: US Blood and Blood Preparations Market (2006 &

2007): Major Import Sources by Country - Germany, UK,

Canada, Switzerland, Belgium and Others (In US$ Million)

(includes corresponding Graph/Chart) 174

Table 40: US Blood and Blood Preparations Market (2006 &

2007): Major Export Destinations by Country - Germany,

Netherlands, UK, Switzerland, Canada and Others (In US$

Million) (includes corresponding Graph/Chart) 174

US Blood Components and Plasma Market Analysis in Units 175

Table 41: US Recent Past, Current & Future Analysis for

Blood Components and Plasma by Product Category - Red Blood

Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets

Independently Analyzed with Annual Consumption in Million

Units for Years 2007 through 2015 (includes corresponding

Graph/Chart) 175

Table 42: US Historic Review for Blood Components and

Plasma by Product Category - Red Blood Cells (RBCs),

Platelets, and Fresh Frozen Plasma Markets Independently

Analyzed with Annual Consumption in Million Units for Years

2001 through 2006 (includes corresponding Graph/Chart) 175

Table 43: US 10-Year Perspective for Blood Components and

Plasma by Product Category - Percentage Breakdown of Volume

Consumption for Red Blood Cells (RBCs), Platelets, and

Fresh Frozen Plasma for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 176

Regulations Control Plasma Collection Industry 176

B.Market Analytics 177

Table 44: US Recent Past, Current & Future Analysis for

Blood Banking and Blood Products by Product Group/ Segment -

Blood Components and Plasma Products (Whole Blood & Cellular

Components, and Plasma Fractions); and Equipment, Blood

Tests and Other Consumables Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 177

Table 45: US Historic Review for Blood Banking and Blood

Products by Product Group/Segment - Blood Components and

Plasma Products (Whole Blood and Cellular Components, and

Plasma Fractions); and Equipment, Blood Tests and Other

Consumables Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 178

Table 46: US 10-Year Perspective for Blood Banking and Blood

Products by Product Group/Segment - Percentage Breakdown of

Value Sales for Blood Components and Plasma Products (Whole

Blood & Cellular Components, and Plasma Fractions); and

Equipment, Blood Tests and Other Consumables Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 179

18. CANADA 180

A.Market Analysis 180

Current and Future Analysis 180

Blood Facts 180

Bleeding Disorders - A Major Threat 180

The 'CSA-Z902-04' - A Comprehensive Voluntary Blood Safety

Standard 180

Blood and Blood Preparations: Import & Export Scenario in

the Recent Past 181

Table 47: Canadian Blood and Blood Preparations Market

(2006 & 2007): Major Import Sources by Country - US, The

Netherlands, Switzerland, Belgium, Italy and Others (In US$

Million) (includes corresponding Graph/Chart) 181

Table 48: Canadian Blood and Blood Preparations Market

(2006 & 2007): Major Export Destinations by Country - US,

France, Chile, Belgium, Germany and Others (In US$ Million)

(includes corresponding Graph/Chart) 181

B.Market Analytics 182

Table 49: Canadian Recent Past, Current & Future Analysis

for Blood Banking and Blood Products by Product

Group/Segment - Blood Components and Plasma Products (Whole

Blood & Cellular Components, and Plasma Fractions); and

Equipment, Blood Tests and Other Consumables Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 182

Table 50: Canadian Historic Review for Blood Banking and

Blood Products by Product Group/Segment - Blood Components

and Plasma Products (Whole Blood & Cellular Components, and

Plasma Fractions); and Equipment, Blood Tests and Other

Consumables Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 183

Table 51: Canadian 10-Year Perspective for Blood Banking and

Blood Products by Product Group/Segment - Percentage

Breakdown of Value Sales for Blood Components and Plasma

Products (Whole Blood & Cellular Components, and Plasma

Fractions); and Equipment, Blood Tests and Other Consumables

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 184

19. JAPAN 185

A.Market Analysis 185

Current and Future Analysis 185

Japan Witnesses Surge in Imported Blood Products 185

Growing Market for Fresh Frozen Plasma 185

Growing Use of Imported Albumin-Based Blood Products 185

The Goal of Self-Sufficiency 186

B.Market Analytics 187

Table 52: Japanese Recent Past, Current & Future Analysis

for Blood Banking and Blood Products by Product

Group/Segment - Blood Components and Plasma Products (Whole

Blood & Cellular Components, and Plasma Fractions); and

Equipment, Blood Tests and Other Consumables Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 187

Table 53: Japanese Historic Review for Blood Banking and

Blood Products by Product Group/Segment - Blood Components

and Plasma Products (Whole Blood & Cellular Components, and

Plasma Fractions); and Equipment, Blood Tests and Other

Consumables Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 188

Table 54: Japanese 10-Year Perspective for Blood Banking and

Blood Products by Product Group/Segment - Percentage

Breakdown of Value Sales for Blood Components and Plasma

Products (Whole Blood & Cellular Components, and Plasma

Fractions); and Equipment, Blood Tests and Other Consumables

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 189

20. EUROPE 190

A.Market Analysis 190

Current & Future Analysis 190

European Blood Banking and Blood Products Market at a

Glance (All figures are 2010 estimates & CAGR is for the

period 2007-2015) 190

Market Trends and Issues 190

Legislations on Payment for Donation Restrict Donors 190

Government's Check on Healthcare Costs Pressurizes BCT

Manufacturers 191

Purchasing System Witnesses Modifications 191

EU Nations Marching Towards Self-Sufficiency in Blood and

Blood Products 191

Blood Banking Devices Market 191

Table 55: European Recent Past, Current & Future Analysis

for Blood Banking Devices - Manual Blood Collection,

Apheresis, and Autologous Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 192

Table 56: European Historic Review for Blood Banking

Devices - Manual Blood Collection, Apheresis, and

Autologous Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006

(includes corresponding Graph/Chart) 193

Table 57: European 10-Year Perspective for Blood Banking

Devices by Product Segment - Manual Blood Collection,

Apheresis, and Autologous Devices Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 193

Table 58: European Blood Banking Devices Market (2007):

Percentage Breakdown of Value Sales by Geographic Region

for France, Germany, Italy, UK, Spain and Rest of Europe

(includes corresponding Graph/Chart) 194

A Snapshot of Health Care Systems Across Select EU Countries 194

France 194

Germany 194

Italy 195

The UK 195

Spain 195

B.Market Analytics 196

Table 59: European Recent Past, Current & Future Analysis

for Blood Banking and Blood Products by Geographic Region -

France, Germany, Italy, UK, Spain, Russia, and Rest of

Europe Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 196

Table 60: European Historic Review for Blood Banking and

Blood Products by Geographic Region - France, Germany,

Italy, UK, Spain, Russia, and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2006 (includes corresponding

Graph/Chart) 197

Table 61: European Recent Past, Current & Future Analysis

for Blood Banking and Blood Products by Product Group/

Segment - Blood Components and Plasma Products (Whole Blood &

Cellular Components, and Plasma Fractions); and Equipment,

Blood Tests and Other Consumables Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) 198

Table 62: European Historic Review for Blood Banking and

Blood Products by Product Group/Segment - Blood Components

and Plasma Products (Whole Blood & Cellular Components, and

Plasma Fractions); and Equipment, Blood Tests and Other

Consumables Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 199

Table 63: European 10-Year Perspective for Blood Banking

and Blood Products by Geographic Region - Percentage

Breakdown of Value Sales for France, Germany, Italy, UK,

Spain, Russia and Rest of Europe Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 200

Table 64: European 10-Year Perspective for Blood Banking and

Blood Products by Product Group/ Segment - Percentage

Breakdown of Value Sales for Blood Components and Plasma

Products (Whole Blood & Cellular Components, and Plasma

Fractions); and Equipment, Blood Tests and Other Consumables

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 201

20a. FRANCE 202

A.Market Analysis 202

Current and Future Analysis 202

B.Market Analytics 202

Table 65: French Recent Past, Current & Future Analysis for

Blood Banking and Blood Products by Product Group/ Segment -

Blood Components and Plasma Products (Whole Blood & Cellular

Components, and Plasma Fractions); and Equipment, Blood

Tests and Other Consumables Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 202

Table 66: French Historic Review for Blood Banking and Blood

Products by Product Group/Segment - Blood Components and

Plasma Products (Whole Blood & Cellular Components, and

Plasma Fractions); and Equipment, Blood Tests and Other

Consumables Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 203

Table 67: French 10-Year Perspective for Blood Banking and

Blood Products by Product Group/Segment - Percentage

Breakdown of Value Sales for Blood Components and Plasma

Products (Whole Blood & Cellular Components, and Plasma

Fractions); and Equipment, Blood Tests and Other Consumables

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 204

20b. GERMANY 205

A.Market Analysis 205

Current and Future Analysis 205

B.Market Analytics 205

Table 68: German Recent Past, Current & Future Analysis for

Blood Banking and Blood Products by Product Group/Segment -

Blood Components and Plasma Products (Whole Blood & Cellular

Components, and Plasma Fractions); and Equipment, Blood

Tests and Other Consumables Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 205

Table 69: German Historic Review for Blood Banking and Blood

Products by Product Group/Segment - Blood Components and

Plasma Products (Whole Blood & Cellular Components, and

Plasma Fractions); and Equipment, Blood Tests and Other

Consumables Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2006 (includes

corresponding Graph/Chart) 206

Table 70: German 10-Year Perspective for Blood Banking and

Blood Products by Product Group/Segment - Percentage

Breakdown of Value Sales for Blood Components and Plasma

Products (Whole Blood & Cellular Components, and Plasma

Fractions); and Equipment, Blood Tests and Other Consumables

Markets for Years 2005, 2010 & 2015 (includes corresponding

Graph/Chart) 207

20c. ITALY

To order this report:

Blood Supply, Tissue Banking and Transplantation Industry: Global Blood Banking and Blood Products Industry

Blood Supply, Tissue Banking and Transplantation Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626



SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com